Stacie A. Dalrymple

3.4k total citations · 1 hit paper
24 papers, 2.5k citations indexed

About

Stacie A. Dalrymple is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Stacie A. Dalrymple has authored 24 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 7 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Stacie A. Dalrymple's work include Immune Response and Inflammation (6 papers), NF-κB Signaling Pathways (3 papers) and Virus-based gene therapy research (2 papers). Stacie A. Dalrymple is often cited by papers focused on Immune Response and Inflammation (6 papers), NF-κB Signaling Pathways (3 papers) and Virus-based gene therapy research (2 papers). Stacie A. Dalrymple collaborates with scholars based in United States, Switzerland and France. Stacie A. Dalrymple's co-authors include María E. Fuentes, Michael Durnin, David V. Goeddel, Toshihiro Yamaguchi, Masato Tanaka, Richard M. Murray, Linda Lucian, Robyn M. Slattery, Dee Aud and Robin Murray and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Blood.

In The Last Decade

Stacie A. Dalrymple

24 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Discovery of Selective Irreversible Inhibitors for Bruton’s Tyrosine Kinase

2006 517 citations Zhengying Pan, Heleen Scheerens et al. ChemMedChem profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stacie A. Dalrymple United States	18	1.0k	892	579	549	344	24	2.5k
Gerald M. Feldman United States	27	1.2k 1.1×	1.3k 1.5×	1.2k 2.1×	336 0.6×	103 0.3×	59	2.9k
Marko Pesu Finland	26	822 0.8×	1.3k 1.5×	1.0k 1.8×	279 0.5×	315 0.9×	62	3.1k
Zhixing K. Pan United States	36	1.6k 1.6×	1.3k 1.5×	668 1.2×	742 1.4×	258 0.8×	61	3.3k
Yoshiki Kawabe Japan	38	1.4k 1.4×	1.2k 1.4×	534 0.9×	399 0.7×	211 0.6×	119	4.4k
Pravin B. Sehgal United States	32	1.3k 1.3×	1.3k 1.5×	893 1.5×	285 0.5×	112 0.3×	79	3.5k
Nathalie Heuzé‐Vourc'h France	31	896 0.9×	692 0.8×	644 1.1×	345 0.6×	326 0.9×	94	2.9k
Richard P. Nordan United States	23	873 0.8×	1.7k 1.9×	647 1.1×	206 0.4×	139 0.4×	39	3.2k
Hirokuni Taguchi Japan	36	1.6k 1.6×	1.2k 1.3×	1.1k 2.0×	291 0.5×	224 0.7×	223	4.5k
Gregory J. Brunn United States	26	2.6k 2.5×	1.2k 1.3×	536 0.9×	296 0.5×	122 0.4×	37	4.3k
H Baumann United States	16	696 0.7×	933 1.0×	751 1.3×	226 0.4×	90 0.3×	27	2.6k

Countries citing papers authored by Stacie A. Dalrymple

Since Specialization

Citations

This map shows the geographic impact of Stacie A. Dalrymple's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stacie A. Dalrymple with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stacie A. Dalrymple more than expected).

Fields of papers citing papers by Stacie A. Dalrymple

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stacie A. Dalrymple. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stacie A. Dalrymple. The network helps show where Stacie A. Dalrymple may publish in the future.

Co-authorship network of co-authors of Stacie A. Dalrymple

This figure shows the co-authorship network connecting the top 25 collaborators of Stacie A. Dalrymple. A scholar is included among the top collaborators of Stacie A. Dalrymple based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stacie A. Dalrymple. Stacie A. Dalrymple is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Elie, Benelita T., Vasilena Gocheva, Tanaya Shree, et al.. (2010). Identification and pre-clinical testing of a reversible cathepsin protease inhibitor reveals anti-tumor efficacy in a pancreatic cancer model. Biochimie. 92(11). 1618–1624. 50 indexed citations

Cao, Zhe, Kathryn E. Bass, Sriram Balasubramanian, et al.. (2006). CRA-026440: a potent, broad-spectrum, hydroxamic histone deacetylase inhibitor with antiproliferative and antiangiogenic activity in vitro and in vivo. Molecular Cancer Therapeutics. 5(7). 1693–1701. 25 indexed citations

Pan, Zhengying, Heleen Scheerens, Shyr‐Jiann Li, et al.. (2006). Discovery of Selective Irreversible Inhibitors for Bruton’s Tyrosine Kinase. ChemMedChem. 2(1). 58–61. 517 indexed citations breakdown →

Spencer, Jeffrey R., Martin Sendzik, Jason Oeh, et al.. (2006). Evaluation of antitumor properties of novel saframycin analogs in vitro and in vivo. Bioorganic & Medicinal Chemistry Letters. 16(18). 4884–4888. 15 indexed citations

Buggy, Joseph J., Zhe Cao, Kathryn E. Bass, et al.. (2006). CRA-024781: a novel synthetic inhibitor of histone deacetylase enzymes with antitumor activity in vitro and in vivo. Molecular Cancer Therapeutics. 5(5). 1309–1317. 97 indexed citations

Dalrymple, Stacie A., et al.. (2005). A Selective Small Molecule Factor VIIa Inhibitor, CRA-027483, Suppresses Acute Inflammation in Mice.. Blood. 106(11). 3089–3089. 1 indexed citations

Marzec, Ulla M., Juthamas Sukbuntherng, Stacie A. Dalrymple, et al.. (2005). Subcutaneous Dosing of CRA-027483, a Small Molecule FVIIa Inhibitor, Prevents Arterial Thrombosis in a Baboon Model.. Blood. 106(11). 1867–1867. 1 indexed citations

Oligino, Thomas J. & Stacie A. Dalrymple. (2003). Targeting B cells for the treatment of rheumatoid arthritis.. Arthritis Research. 5(Suppl 4). S7–S7. 19 indexed citations

Dalrymple, Stacie A.. (2002). p38 Mitogen Activated Protein Kinase as a Therapeutic Target for Alzheimer's Disease. Journal of Molecular Neuroscience. 19(3). 295–300. 24 indexed citations

10.

Swinney, David C., Chakkodabylu S. Ramesha, Mary A. Mulkins, et al.. (2002). A Small Molecule Ubiquitination Inhibitor Blocks NF-κB-dependent Cytokine Expression in Cells and Rats. Journal of Biological Chemistry. 277(26). 23573–23581. 74 indexed citations

11.

Whiteley, Phyllis E. & Stacie A. Dalrymple. (2001). Models of Inflammation: Adjuvant‐Induced Arthritis in the Rat. Current Protocols in Pharmacology. 13(1). Unit5.5–Unit5.5. 30 indexed citations

12.

Tanaka, Masato, María E. Fuentes, Toshihiro Yamaguchi, et al.. (1999). Embryonic Lethality, Liver Degeneration, and Impaired NF-κB Activation in IKK-β-Deficient Mice. Immunity. 10(4). 421–429. 487 indexed citations

13.

Cao, Zhijian, Masao Tanaka, Catherine H. Régnier, et al.. (1999). NF- B Activation by Tumor Necrosis Factor and Interleukin-1. Cold Spring Harbor Symposia on Quantitative Biology. 64(0). 473–484. 47 indexed citations

14.

Szalai, Alexander J., Frederik W. van Ginkel, Stacie A. Dalrymple, et al.. (1998). Testosterone and IL-6 Requirements for Human C-Reactive Protein Gene Expression in Transgenic Mice. The Journal of Immunology. 160(11). 5294–5299. 103 indexed citations

15.

Whiteley, Phyllis E. & Stacie A. Dalrymple. (1998). Models of Inflammation: Measuring Gastrointestinal Ulceration in the Rat. Current Protocols in Pharmacology. 0(1). Unit 10.2–Unit 10.2. 5 indexed citations

16.

Mocci, Simonetta, Stacie A. Dalrymple, Ryuichi Nishinakamura, & Richard M. Murray. (1997). The cytokine stew and innate resistance to L. monocytogenes. Immunological Reviews. 158(1). 107–114. 40 indexed citations

17.

Suzuki, Yasuhiro, Seema Rani, Oliver Liesenfeld, et al.. (1997). Impaired resistance to the development of toxoplasmic encephalitis in interleukin-6-deficient mice. Infection and Immunity. 65(6). 2339–2345. 112 indexed citations

18.

Bellido, Teresita, R L Jilka, Brendan F. Boyce, et al.. (1995). Regulation of interleukin-6, osteoclastogenesis, and bone mass by androgens. The role of the androgen receptor.. Journal of Clinical Investigation. 95(6). 2886–2895. 349 indexed citations

19.

Dalrymple, Stacie A., Linda Lucian, Robyn M. Slattery, et al.. (1995). Interleukin-6-deficient mice are highly susceptible to Listeria monocytogenes infection: correlation with inefficient neutrophilia. Infection and Immunity. 63(6). 2262–2268. 237 indexed citations

20.

Dalrymple, Stacie A., et al.. (1989). Age-related demethylation of mouse satelite DNA is easily detectable by HPLC but not by restriction endonucleases. Mutation Research/DNAging. 219(2). 101–106. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact